InsidersTradesSigma
Track the 바디텍메드 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바디텍메드 has logged 21 reports. Market capitalisation: €243.8bn. The latest transaction was disclosed on 7 April 2026 (Other). Among the most active insiders: 박대균. Every trade is accessible without an account.
21
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,697 of 29,064 companies
69.3
score / 100
Value63
Quality75
FCF yld-4.9%
Earn yld9.7%
EV/EBITDA6.8x
ROE11%
Gross mgn59%
Net mgn15%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 April 2026
Declarations21 total
21 of 21 declarations
关于 바디텍메드
Bodytechmed 是一家专注于体外诊断设备开发的医疗保健和制药公司。该公司在 XKRX 市场上市。